Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21055665 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Sublingual Immunotherapy In Alternaria-Induced Rhinitis
Condition: Allergic Rhinitis (w/w Asthma) Due to Alternaria Alternata
Interventions: Biological: sublingual immunotherapy;   Biological: placebo

Indicates status has not been verified in more than two years